Volume 7 Issue 295
Published - 14:00 UTC 08:00 EST 6-Nov-2005 
Next Update - 14:00 UTC 08:00 EST 7-Nov-2005

Editor: Susan K. Boyer, RN
© Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.

  

 


Vagus nerve stimulation (VNS) therapy: Implantable device specifically indicated for long-term treatment of treatment resistant depression (TRD)

New York-Presbyterian Hospital/Columbia University Medical Center is the first in the greater New York City-area to offer Vagus Nerve Stimulation (VNS) Therapy as a long-term treatment specifically approved by the FDA for treatment-resistant depression (TRD). more  

Reflecting on personal values offers protection from effects of stress, UCLA psychologists report

Reflecting on meaningful values provides biological and psychological protection from the adverse effects of stress, UCLA psychologists report in the November issue of the journal Psychological Science. more

HIV-infected adults in Botswana respond positively to ARV therapy public treatment program

With preliminary results from a study in Botswana, Harvard School of Public Health researchers have found that people with HIV-1 subtype C in resource-poor settings, who receive antiretroviral (ARV) therapy, can achieve comparable results to those in the developed world. A fully supported health care delivery system and infrastructure help ensure this success, according to data published in November 2005 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS). more  

Study broadens understanding of enzymes linked to tumor promoting molecule

Virginia Commonwealth University Massey Cancer Center researchers have found that two enzymes that catalyze the same reaction and produce the same product have opposite effects on cell growth and death. more

Researchers looking at how neighborhoods contribute to healthy lifestyles  

New preliminary research findings show frontline healthcare providers are not following guidelines on the management of anaphylaxis, a severe allergic reaction, according to findings presented during the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim. more

Lancet study: Pfizer's Vfend equals two-drug candidemia regimen, with fewer serious side effects 

Using Vfend® (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen. This is based on a study published in The Lancet in October. more

Obesity measure should be redefined to accurately assess heart attack risk

Waist-to-hip ratio, not body mass index (BMI), is the best obesity measure for assessing a person's risk of heart attack, concludes a global study published in this week's issue of The Lancet. more

 

Waist-to-hip ratio is three times stronger than BMI in predicting the risk of a heart attack